Loading company…
VACURE Biotechnology develops point-of-care diagnostic products and equipment.
Established in 2017 and based in Chengdu, China, VACURE Biotechnology develops and manufactures point-of-care testing products. Its offerings include microfluidic diagnostic platforms, test kits, monoclonal antibodies, and related reagents for infectious and cardiovascular disease testing. The company plans to grow its market share in China and develop tests for common chronic diseases in the home.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in